Literature DB >> 30753827

DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.

Ksenia Skvortsova1, Etienne Masle-Farquhar2, Phuc-Loi Luu3, Jenny Z Song3, Wenjia Qu3, Elena Zotenko3, Cathryn M Gould3, Qian Du3, Timothy J Peters3, Yolanda Colino-Sanguino3, Ruth Pidsley3, Shalima S Nair3, Amanda Khoury3, Grady C Smith3, Lisa A Miosge4, Joanne H Reed2, James G Kench5, Mark A Rubin6, Lisa Horvath7, Ozren Bogdanovic8, Sue Mei Lim9, Jose M Polo9, Christopher C Goodnow10, Clare Stirzaker11, Susan J Clark12.   

Abstract

Promoter CpG islands are typically unmethylated in normal cells, but in cancer a proportion are subject to hypermethylation. Using methylome sequencing we identified CpG islands that display partial methylation encroachment across the 5' or 3' CpG island borders. CpG island methylation encroachment is widespread in prostate and breast cancer and commonly associates with gene suppression. We show that the pattern of H3K4me1 at CpG island borders in normal cells predicts the different modes of cancer CpG island hypermethylation. Notably, genetic manipulation of Kmt2d results in concordant alterations in H3K4me1 levels and CpG island border DNA methylation encroachment. Our findings suggest a role for H3K4me1 in the demarcation of CpG island methylation borders in normal cells, which become eroded in cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-hydroxymethylation; BisChIP-seq; CpG islands; DNA methylation encroachment; H3K4 monomethylation; TAB-seq; WGBS; cancer; hypermethylation

Year:  2019        PMID: 30753827     DOI: 10.1016/j.ccell.2019.01.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  27 in total

Review 1.  Protein Interactions at Oxidized 5-Methylcytosine Bases.

Authors:  Gerd P Pfeifer; Piroska E Szabó; Jikui Song
Journal:  J Mol Biol       Date:  2019-08-08       Impact factor: 5.469

2.  Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.

Authors:  Sietse M Aukema; Selina Glaser; Mari F C M van den Hout; Sonja Dahlum; Marinus J Blok; Morten Hillmer; Julia Kolarova; Raf Sciot; Dina A Schott; Reiner Siebert; Constance T R M Stumpel
Journal:  Fam Cancer       Date:  2022-07-19       Impact factor: 2.446

3.  Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.

Authors:  Jae Young So; Nicolas Skrypek; Howard H Yang; Anand S Merchant; George W Nelson; Wei-Dong Chen; Hiroki Ishii; Jennifer M Chen; Gangqing Hu; Bhagelu R Achyut; Esther C Yoon; Liying Han; Chuanshu Huang; Margaret C Cam; Keji Zhao; Maxwell P Lee; Li Yang
Journal:  Cancer Res       Date:  2020-04-07       Impact factor: 12.701

4.  A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.

Authors:  Han Chen; Han Liang
Journal:  Cancer Cell       Date:  2020-10-01       Impact factor: 31.743

Review 5.  Molecular tracing of prostate cancer lethality.

Authors:  Yuanshuo Alice Wang; John Sfakianos; Ashutosh K Tewari; Carlos Cordon-Cardo; Natasha Kyprianou
Journal:  Oncogene       Date:  2020-10-12       Impact factor: 9.867

Review 6.  The interplay between DNA and histone methylation: molecular mechanisms and disease implications.

Authors:  Yinglu Li; Xiao Chen; Chao Lu
Journal:  EMBO Rep       Date:  2021-04-12       Impact factor: 8.807

Review 7.  Epigenetic reprogramming during prostate cancer progression: A perspective from development.

Authors:  Sakshi Goel; Vipul Bhatia; Tanay Biswas; Bushra Ateeq
Journal:  Semin Cancer Biol       Date:  2021-02-02       Impact factor: 17.012

8.  Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue.

Authors:  Owen M Wilkins; Kevin C Johnson; E Andres Houseman; Jessica E King; Carmen J Marsit; Brock C Christensen
Journal:  Epigenetics       Date:  2019-12-16       Impact factor: 4.528

9.  Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer.

Authors:  Mark D Long; Vineet K Dhiman; Hayley C Affronti; Qiang Hu; Song Liu; Dominic J Smiraglia
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  SIRT1/2 orchestrate acquisition of DNA methylation and loss of histone H3 activating marks to prevent premature activation of inflammatory genes in macrophages.

Authors:  Tianlu Li; Antonio Garcia-Gomez; Octavio Morante-Palacios; Laura Ciudad; Sevgi Özkaramehmet; Evelien Van Dijck; Javier Rodríguez-Ubreva; Alejandro Vaquero; Esteban Ballestar
Journal:  Nucleic Acids Res       Date:  2020-01-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.